Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Bladder Cancer

  Free Subscription


30.12.2018

1 ACS Nano
1 Biochem Biophys Res Commun
1 Cancer Discov
1 Cancer Lett
1 Clin Genitourin Cancer
1 Eur Rev Med Pharmacol Sci
1 Front Cell Infect Microbiol
1 Int J Radiat Oncol Biol Phys
3 J Cancer
1 J Cancer Res Ther
1 J Cell Mol Med
2 J Urol
1 Med Sci Monit
1 Medicine (Baltimore)
1 Mol Med Rep
1 Nat Rev Urol
1 Nutr Cancer
1 Onco Targets Ther
1 Pathol Res Pract
1 Surg Pathol Clin
1 Toxicology
1 Urol J
2 Urol Oncol
1 Urologiia


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    ACS Nano

  1. HORTELAO AC, Carrascosa R, Murillo-Cremaes N, Patino T, et al
    Targeting 3D Bladder Cancer Spheroids with Urease-Powered Nanomotors.
    ACS Nano. 2018 Dec 27. doi: 10.1021/acsnano.8b06610.
    PubMed     Text format     Abstract available


    Biochem Biophys Res Commun

  2. CHO MJ, Kim MJ, Kim K, Choi YW, et al
    The immunotherapeutic effects of recombinant Bacillus Calmette-Guerin resistant to antimicrobial peptides on bladder cancer cells.
    Biochem Biophys Res Commun. 2018 Dec 19. pii: S0006-291X(18)32746.
    PubMed     Text format     Abstract available


    Cancer Discov

  3. DUDLEY JC, Schroers-Martin J, Lazzareschi DV, Shi WY, et al
    Detection and surveillance of bladder cancer using urine tumor DNA.
    Cancer Discov. 2018 Dec 21. pii: 2159-8290.CD-18-0825.
    PubMed     Text format     Abstract available


    Cancer Lett

  4. WANG H, Huang Y, Shi J, Zhi Y, et al
    XPC deficiency leads to centrosome amplification by inhibiting BRCA1 expression upon cisplatin-mediated DNA damage in human bladder cancer.
    Cancer Lett. 2018 Dec 20. pii: S0304-3835(18)30719.
    PubMed     Text format     Abstract available


    Clin Genitourin Cancer

  5. GREENFIELD RS, Herd TM, Date K, Cooper P, et al
    Signal Transduction Peptide of Tissue Factor Phosphorylated at Ser258 and the Unphosphorylated STP in Urine Are Potential Biomarkers for Bladder Cancer.
    Clin Genitourin Cancer. 2018 Nov 17. pii: S1558-7673(18)30188.
    PubMed     Text format     Abstract available


    Eur Rev Med Pharmacol Sci

  6. YU QF, Liu P, Li ZY, Zhang CF, et al
    MiR-103/107 induces tumorigenicity in bladder cancer cell by suppressing PTEN.
    Eur Rev Med Pharmacol Sci. 2018;22:8616-8623.
    PubMed     Text format     Abstract available


    Front Cell Infect Microbiol

  7. WU P, Zhang G, Zhao J, Chen J, et al
    Corrigendum: Profiling the Urinary Microbiota in Male Patients With Bladder Cancer in China.
    Front Cell Infect Microbiol. 2018;8:429.
    PubMed     Text format     Abstract available


    Int J Radiat Oncol Biol Phys

  8. MENG W, Efstathiou J, Singh R, McElroy J, et al
    MicroRNA biomarkers for patients with muscle-invasive bladder cancer undergoing selective bladder sparing trimodality treatment.
    Int J Radiat Oncol Biol Phys. 2018 Dec 21. pii: S0360-3016(18)34194.
    PubMed     Text format     Abstract available


    J Cancer

  9. CHEN JB, Zhang M, Zhang XL, Cui Y, et al
    Glucocorticoid-Inducible Kinase 2 Promotes Bladder Cancer Cell Proliferation, Migration and Invasion by Enhancing beta-catenin/c-Myc Signaling Pathway.
    J Cancer. 2018;9:4774-4782.
    PubMed     Text format     Abstract available

  10. WANG D, Chen Z, Lin F, Wang Z, et al
    OIP5 Promotes Growth, Metastasis and Chemoresistance to Cisplatin in Bladder Cancer Cells.
    J Cancer. 2018;9:4684-4695.
    PubMed     Text format     Abstract available

  11. ZHANG C, Liu L, Tao F, Guo X, et al
    Bone Metastases Pattern in Newly Diagnosed Metastatic Bladder Cancer: A Population-Based Study.
    J Cancer. 2018;9:4706-4711.
    PubMed     Text format     Abstract available


    J Cancer Res Ther

  12. CHENG YY, Sun Y, Li J, Liang L, et al
    Transurethral endoscopic submucosal en bloc dissection for nonmuscle invasive bladder cancer: A comparison study of HybridKnife-assisted versus conventional dissection technique.
    J Cancer Res Ther. 2018;14:1606-1612.
    PubMed     Text format     Abstract available


    J Cell Mol Med

  13. PIAO C, Cui X, Zhan B, Li J, et al
    Inhibition of stearoyl CoA desaturase-1 activity suppresses tumour progression and improves prognosis in human bladder cancer.
    J Cell Mol Med. 2018 Dec 27. doi: 10.1111/jcmm.14114.
    PubMed     Text format     Abstract available


    J Urol

  14. CHANG SS
    Re: Pathologic Response in Patients Receiving Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer: Is Therapeutic Effect Owing to Chemotherapy or TURBT?
    J Urol. 2019;201:30.
    PubMed     Text format    

  15. CHANG SS
    Re: Adjuvant Sandwich Chemotherapy plus Radiotherapy vs Adjuvant Chemotherapy Alone for Locally Advanced Bladder Cancer after Radical Cystectomy: A Randomized Phase 2 Trial.
    J Urol. 2019;201:29.
    PubMed     Text format    


    Med Sci Monit

  16. WANG J, Yang K, Yuan W, Gao Z, et al
    Determination of Serum Exosomal H19 as a Noninvasive Biomarker for Bladder Cancer Diagnosis and Prognosis.
    Med Sci Monit. 2018;24:9307-9316.
    PubMed     Text format     Abstract available


    Medicine (Baltimore)

  17. XU H, He B, Tu X, Bao Y, et al
    Minimally invasive surgery for inflammatory myofibroblastic tumor of the urinary bladder: Three case reports.
    Medicine (Baltimore). 2018;97:e13474.
    PubMed     Text format     Abstract available


    Mol Med Rep

  18. LIU X, Xu X, Deng W, Huang M, et al
    CCL18 enhances migration, invasion and EMT by binding CCR8 in bladder cancer cells.
    Mol Med Rep. 2018 Dec 24. doi: 10.3892/mmr.2018.9791.
    PubMed     Text format     Abstract available


    Nat Rev Urol

  19. TEO MY, Rosenberg JE
    Refining existing knowledge and management of bladder cancer.
    Nat Rev Urol. 2018 Dec 21. pii: 10.1038/s41585-018-0137.
    PubMed     Text format    


    Nutr Cancer

  20. HONG X, Xu Q, Lan K, Huang H, et al
    The Effect of Daily Fluid Management and Beverages Consumption on the Risk of Bladder Cancer: A Meta-analysis of Observational Study.
    Nutr Cancer. 2018 Dec 23:1-11. doi: 10.1080/01635581.2018.1512636.
    PubMed     Text format     Abstract available


    Onco Targets Ther

  21. LIU Y, Liu T, Jin H, Yin L, et al
    MiR-411 suppresses the development of bladder cancer by regulating ZnT1.
    Onco Targets Ther. 2018;11:8695-8704.
    PubMed     Text format     Abstract available


    Pathol Res Pract

  22. SHI Z, Kadeer A, Wang M, Wen B, et al
    The deregulation of miR-133b is associated with poor prognosis in bladder cancer.
    Pathol Res Pract. 2018 Nov 24. pii: S0344-0338(18)31307.
    PubMed     Text format     Abstract available


    Surg Pathol Clin

  23. XING J, Reynolds JP
    Diagnostic Advances in Urine Cytology.
    Surg Pathol Clin. 2018;11:601-610.
    PubMed     Text format     Abstract available


    Toxicology

  24. SUZUKI S, Cohen SM, Arnold LL, Kato H, et al
    Orally administered nicotine effects on rat urinary bladder proliferation and carcinogenesis.
    Toxicology. 2018;398-399:31-40.
    PubMed     Text format     Abstract available


    Urol J

  25. JAVANMARD B, Barghi MR, Amani D, Fallah Karkan M, et al
    Human Papilloma Virus DNA in Tumor Tissue and Urine in Different Stage of Bladder Cancer.
    Urol J. 2018 Dec 8. pii: 4181/1322.
    PubMed     Text format     Abstract available


    Urol Oncol

  26. PHAM H, Torres H, Sharma P
    Mental health implications in bladder cancer patients: A review.
    Urol Oncol. 2018 Dec 21. pii: S1078-1439(18)30498.
    PubMed     Text format     Abstract available

  27. KIMURA S, D' Andrea D, Soria F, Foerster B, et al
    Prognostic value of modified Glasgow Prognostic Score in non-muscle-invasive bladder cancer.
    Urol Oncol. 2018 Dec 20. pii: S1078-1439(18)30451.
    PubMed     Text format     Abstract available


    Urologiia

  28. GLUKHOV AI, Polotdykova NV, Gordeev SA, Vinarov AZ, et al
    [Current trends in bladder cancer diagnosis].
    Urologiia. 2018;:100-105.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Bladder Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: